Skip to main content
. 2019 Jan 25;10(8):810–824. doi: 10.18632/oncotarget.26574

Table 1. Characteristics and TGFβ response of NSCLC cell lines.

Tumor Type Adenocarcinoma Cell Line
EGFR wild type A549, Calu-6, H23, H292, H322, H358, H441, H522, H1395, H1437, H1648, H1944, H2122, H2347
KRAS wild type H292, H322, H522, H1395, H1437, H1648, H2347
KRAS mutant A549, Calu-6, H23, H358, H441, H1944, H2122
Primary lesions A549, Calu-6, H23, H322, H522, H358, H1395, H2347
Metastatic lesions H292, H441, H1437, H1648, H1944, H2122
Response to TGFβ
Growth Inhibition A549, H23, H441, H1944
Smad2-p A549, Calu-6, H23, H292, H322, H358, H441, H1395, H1437, H1944, H2122, H2347
Decreased E-cadherin 1 A549, H358, H1944
Increased Migration A549, H358, H1944